Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,098 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HIV Pol: does it offer therapeutic targets for HIV?
Muccini C, Castagna A. Muccini C, et al. Among authors: castagna a. Expert Opin Ther Targets. 2024 May;28(5):341-343. doi: 10.1080/14728222.2024.2351510. Epub 2024 May 9. Expert Opin Ther Targets. 2024. PMID: 38696265 No abstract available.
Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients.
Gianotti N, Poli A, Galli L, Franzin M, Tadini P, Galizzi N, Carbone A, Merli M, Muccini C, Oltolini C, Andolina A, Spagnuolo V, Lazzarin A, Castagna A. Gianotti N, et al. Among authors: castagna a. PLoS One. 2017 Aug 1;12(8):e0182007. doi: 10.1371/journal.pone.0182007. eCollection 2017. PLoS One. 2017. PMID: 28763473 Free PMC article.
An observational, retrospective analysis evaluating switching to raltegravir plus abacavir/lamivudine in HIV-1-infected patients: the ORASWIRAL study.
Galli L, Poli A, Muccini C, Galizzi N, Danise A, Spagnuolo V, Gianotti N, Carini E, Lazzarin A, Castagna A. Galli L, et al. Among authors: castagna a. Infect Dis (Lond). 2018 Mar;50(3):220-222. doi: 10.1080/23744235.2017.1374552. Epub 2017 Sep 11. Infect Dis (Lond). 2018. PMID: 28891371 No abstract available.
Brief Report: Hyperbilirubinemia Is Associated With a Decreased Risk of Carotid Atherosclerosis in HIV-Infected Patients on Virological Suppression.
Muccini C, Galli L, Poli A, Carbone A, Maillard M, Giusti MC, Spagnuolo V, Bigoloni A, Guffanti M, Gianotti N, Lazzarin A, Castagna A. Muccini C, et al. Among authors: castagna a. J Acquir Immune Defic Syndr. 2018 Dec 15;79(5):617-623. doi: 10.1097/QAI.0000000000001854. J Acquir Immune Defic Syndr. 2018. PMID: 30204718
Retrospective study on the outcome of two-drug regimens based on dolutegravir plus one reverse transcriptase inhibitor in virologically-suppressed HIV-infected patients.
Galizzi N, Poli A, Galli L, Muccini C, Mastrangelo A, Dell'Acqua R, Maillard M, Bossolasco S, Cinque P, Lazzarin A, Castagna A, Gianotti N. Galizzi N, et al. Among authors: castagna a. Int J Antimicrob Agents. 2020 Mar;55(3):105893. doi: 10.1016/j.ijantimicag.2020.105893. Epub 2020 Jan 9. Int J Antimicrob Agents. 2020. PMID: 31926287
1,098 results